Clinical Phenotypes of Heart Failure Patients with Supranormal Ejection Fraction
ESC Heart Failure · 2024
DOI: 10.1002/ehf2.15021 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Liyan Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of…. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Phenotype. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, National High-Level Hospital Clinical Research Funding, CAMS Innovation Fund for Medical Sciences.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Heart failure (HF) with supranormal ejection fraction (HFsnEF) represents a distinct clinical entity characterized by limited treatment options and an unfavourable prognosis. Revealing its phenotypic diversity is crucial for understanding disease mechanism and optimizing patient management. We aim to identify phenotypic subgroups in HFsnEF using unsupervised clustering analysis.
Methods
Consecutive hospitalized patients with a diagnosis of HF and a left ventricular ejection fraction ≥65% at baseline echocardiographic evaluations were included for analysis. We conducted unsupervised hierarchical clustering analysis on principal components (HCPC) to identify HFsnEF phenogroups using mixed data variables including demographics, HF duration, vital signs, anthropometrics, smoking/drinking status, HF aetiology, comorbid diseases, laboratory tests and echocardiographic parameters. We then employed decision tree modelling to identify parameters capable of distinguishing distinct clusters. Clinical outcomes, including all-cause death, cardiovascular (CV) death and CV readmission for different clusters, were examined.
Results
Three mutually exclusive clusters were identified from the cohort of 221 HFsnEF patients. Cluster 1 (52.5%) predominantly consisted of patients with valvular heart disease, who had larger cardiac chambers and a higher prevalence of atrial fibrillation/atrial flutter. Cluster 2 (26.2%) primarily comprised older ischaemic patients with a higher prevalence of metabolic comorbidities. Cluster 3 (21.3%) were mainly hypertrophic cardiomyopathy patients. Two clinical variables were identified that could be used to group all HFsnEF patients into one of the clusters; they were HF aetiology and comorbid diabetes. During the median follow-up of 53.4 months, 46 (20.8%) all-cause deaths occurred, among them 39 of CV causes. Seventy (31.7%) patients experienced CV readmissions. Three clusters showed distinct differences in mortality outcomes, with Cluster 1 exhibiting the highest risk of all-cause mortality [Cluster 1 vs. Cluster 2: adjusted hazard ratio (aHR) = 3.32, P = 0.022; Cluster 1 vs. Cluster 3: aHR = 3.81, P = 0.036; Cluster 2 vs. Cluster 3: aHR = 1.15, P = 0.865] and CV mortality (Cluster 1 vs. Cluster 2: aHR = 3.73, P = 0.022; Cluster 1 vs. Cluster 3: aHR = 4.27, P = 0.020; Cluster 2 vs. Cluster 3: aHR = 1.15, P = 0.870). CV readmission risk was comparable among the three clusters (Cluster 1 vs. Cluster 2: aHR = 0.82, P = 0.590; Cluster 1 vs. Cluster 3: aHR = 1.04, P = 0.900; Cluster 2 vs. Cluster 3: aHR = 1.28, P = 0.580).
Conclusions
In a heterogeneous HFsnEF cohort, three clusters were identified by unsupervised HCPC with distinct clinical characteristics and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Heart Failure Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS and PUMC), Be…
Förderung
- Natural Science Foundation of Beijing Municipality
- National High-Level Hospital Clinical Research Funding
- CAMS Innovation Fund for Medical Sciences
- Key Projects in the National Science and Technology Pillar Program of the 13th Five-Year Plan Period
Zitieren
APA
Huang, L., Feng, J., Zhai, M., Huang, Y., Zhou, Q., Zhang, Y., & Zhang, J. (2024). Clinical Phenotypes of Heart Failure Patients with Supranormal Ejection Fraction. ESC Heart Failure. https://doi.org/10.1002/ehf2.15021
Vancouver
Huang L, Feng J, Zhai M, Huang Y, Zhou Q, Zhang Y, et al. Clinical Phenotypes of Heart Failure Patients with Supranormal Ejection Fraction. ESC Heart Failure. 2024. doi:10.1002/ehf2.15021
BibTeX
@article{Huang2024,
author = {Huang, Liyan and Feng, Jiayu and Zhai, Mei and Huang, Yan and Zhou, Qiong and Zhang, Yuhui and Zhang, Jian},
title = {Clinical Phenotypes of Heart Failure Patients with Supranormal Ejection Fraction},
journal = {ESC Heart Failure},
year = {2024},
doi = {10.1002/ehf2.15021}
}
EUVIMED